Effects of resveratrol on the insulin signaling pathway of obese mice

Journal of Veterinary Science

Volumn 15, Issue 2, 2014, Pages 179-185

  Hong, Hyun Ju ^a   Kang, Wonyoung ^a   Kim, Dong Geon ^a   Lee, Dae Ho ^b   Lee, Youngjae ^a   Han, Chang Hoon ^a  

^a Jeju National University   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

Akt phosphorylation; Antibody array; Insulin signaling pathway; Obese mice; Resveratrol

Indexed keywords

ANTIINFLAMMATORY AGENT; INSULIN; PROTEIN; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; C57BL MOUSE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FLUORESCENT ANTIBODY TECHNIQUE; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PHOSPHORYLATION; PROTEINS; SIGNAL TRANSDUCTION; STILBENES;

EID: 84902341022     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2014.15.2.179     Document Type: Article

References (22)

1. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366, 1059-1062.
2. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
3. Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001, 3, 1041-1064.
4. Casamayor A, Morrice NA, Alessi DR. Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositidedependent protein kinase-1: Identification of five sites of phosphorylation in vivo. Biochem J 1999, 342, 287-292.
5. Conus NM, Hannan KM, Cristiano BE, Hemmings BA, Pearsom RB. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J Biol Chem 2002, 277, 38021-38028.
6. Duffy SJ, Vita JA. Effects of phenolics on vascular endothelial function. Curr Opin Lipidol 2003, 14, 21-27.
7. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997, 61, 2103-2110.
8. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 341, 1103-1104.
9. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003, 88, 1082-1088.
10. 2. Cancer Res 1999, 59, 2596-2601.
11. Kang W, Hong HJ, Guan J, Kim DG, Yang EJ, Koh G, Park D, Han CH, Lee YJ, Lee DH. Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism. 2012, 61, 424-433.
12. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127, 1109-1122.
13. Li X, Lu Y, Jin W, Liang K, Mills GB, Fan Z. Autophosphorylation of Akt at threonine 72 and serine 246. A potential mechanism of regulation of Akt kinase activity. J Biol Chem 2006, 281, 13837-13843.
14. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 2005, 24, 1571-1583.
15. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996, 246, 163-182.
16. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008, 118, 829-838.
17. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
18. Sipula IJ, Brown NF, Perdomo G. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation. Metabolism 2006, 55, 1637-1644.
19. Soleas GJ, Diamandis EP, Goldberg DM. The world of resveratrol. Adv Exp Med Biol 2001, 492, 159-182.
20. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (Type II) diabetes independent of impaired glucose uptake. J Clin Invest 1990, 85, 522-529.
21. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006, 16, 296-300.
22. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002, 283, E413-422.